<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04806399</url>
  </required_header>
  <id_info>
    <org_study_id>Cure 16</org_study_id>
    <nct_id>NCT04806399</nct_id>
  </id_info>
  <brief_title>Improving Utilization of Lung Cancer Screening in Underserved PA Populations</brief_title>
  <official_title>Improving Utilization of Lung Cancer Screening in Underserved PA Populations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>American College of Radiology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>American College of Radiology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is an interventional study intended to assess the impact of a centralized outreach&#xD;
      intervention that includes shared decision-making about lung cancer screening (LCS) in&#xD;
      LCS-eligible primary care patients. The study's goal is to increase LCS rates compared to&#xD;
      usual care and thus reduce lung cancer deaths.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The research team will select primary care practices included in areas where lung cancer&#xD;
      mortality is high. An outreach registry of primary care patients obtaining care at&#xD;
      participating practices who meet study eligibility criteria will be created from the&#xD;
      electronic medical record. 500 primary care patients will be randomly selected for the&#xD;
      Outreach Contact with Decision Counseling (OCDC) Group from this outreach registry. Patients&#xD;
      targeted for inclusion in the study will have a scheduled primary care appointment 18-23 days&#xD;
      after initial outreach contact.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2021</start_date>
  <completion_date type="Anticipated">May 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be randomly selected for assignment to the Outreach Contact with Decision Counseling Group or randomly selected for assignment to a Usual Care Control Group</intervention_model_description>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assess impact of a centralized outreach intervention that includes shared decision-making (SDM) on lung cancer screening rates compared to usual care.</measure>
    <time_frame>24 months</time_frame>
    <description>Implement a centralized outreach intervention that includes shared decision-making (SDM) about lung cancer screening (LCS) (screening eligibility assessment, education, and decision support) in LCS-eligible primary care patients. The study's ultimate goal is to increase LCS rates compared to usual care and thus reduce lung cancer deaths.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2500</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Usual Care Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Outreach Contact with Decision Counseling Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Educational Materials and Decision Counseling</intervention_name>
    <description>Participants in the active comparator arm will receive an introductory letter and lung cancer screening educational materials. A site care coordinator will contact each participant post receiving materials.</description>
    <arm_group_label>Outreach Contact with Decision Counseling Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Have an upcoming office visit with a primary care physician in one of the study&#xD;
             practices&#xD;
&#xD;
          -  Between the ages of 55 and 77 (inclusive)&#xD;
&#xD;
          -  History of smoking (current or former) in the electronic medical record (EMR)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chest CT performed in the last 12 months before study initiation according to EMR&#xD;
&#xD;
          -  Diagnosis of lung cancer indicated in the problem list in the EMR&#xD;
&#xD;
          -  Primary language is not English&#xD;
&#xD;
          -  Current cancer treatment or other qualifying diagnoses that would make outreach&#xD;
             inappropriate (e.g., dementia, hearing disability)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>77 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Etta Pisano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>American College of Radiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ronald Myers, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Jefferson Health System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Irene Mahon</last_name>
    <phone>215-574-3249</phone>
    <email>imahon@acr.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Donna Hartfeil</last_name>
    <phone>215-717-2765</phone>
    <email>dhartfeil@acr.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lehigh Valley Health Network</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18105</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Melanie Johnson, MPA</last_name>
      <phone>484-862-3073</phone>
      <email>melanie_bjohnson@lvhn.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jefferson Health System</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Melissa DiCarlo, MPH, MS</last_name>
      <phone>215-503-9348</phone>
      <email>melissa.dicarlo@jefferson.edu</email>
    </contact>
    <investigator>
      <last_name>Ronald Myers, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>January 8, 2021</study_first_submitted>
  <study_first_submitted_qc>March 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2021</study_first_posted>
  <last_update_submitted>March 16, 2021</last_update_submitted>
  <last_update_submitted_qc>March 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Screening Utilization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

